DAWES KAREN A
CIK: 0001261506
Director
Primary company: REPLIGEN CORP (RGEN)
DAWES KAREN A is a corporate insider at REPLIGEN CORP (RGEN) filing SEC Form 4 transactions. 236 transactions across 5 companies, totaling $128,638 in purchases and $18,967,930 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
REPLIGEN CORP RGEN | Sale | 275 | $161.00 | $44K | 91,821 | 12/17/2025 Filed: 12/18/2025 | Filing → |
| Award | 20,174 | - | - | 20,174 | 6/10/2025 Filed: 6/11/2025 | Filing → | |
REPLIGEN CORP RGEN | Award | 1,800 | - | - | 1,800 | 5/15/2025 Filed: 5/19/2025 | Filing → |
REPLIGEN CORP RGEN | Award | 973 | - | - | 92,096 | 5/15/2025 Filed: 5/19/2025 | Filing → |
REPLIGEN CORP RGEN | Exercise | 2,953 | - | - | 0 | 6/14/2024 Filed: 6/14/2024 | Filing → |
REPLIGEN CORP RGEN | Exercise | 2,953 | $67.71 | $200K | 88,170 | 6/14/2024 Filed: 6/14/2024 | Filing → |
REPLIGEN CORP RGEN | Award | 1,576 | - | - | 1,576 | 5/16/2024 Filed: 5/20/2024 | Filing → |
REPLIGEN CORP RGEN | Award | 803 | - | - | 88,170 | 5/16/2024 Filed: 5/20/2024 | Filing → |
| Award | 19,516 | - | - | 19,516 | 5/10/2024 Filed: 5/14/2024 | Filing → | |
REPLIGEN CORP RGEN | Exercise | 4,626 | - | - | 0 | 2/27/2024 Filed: 2/28/2024 | Filing → |
REPLIGEN CORP RGEN | Sale | 1,000 | $193.35 | $193K | 87,367 | 2/27/2024 Filed: 2/28/2024 | Filing → |
REPLIGEN CORP RGEN | Exercise | 4,626 | $42.07 | $195K | 88,367 | 2/27/2024 Filed: 2/28/2024 | Filing → |
REPLIGEN CORP RGEN | Exercise | 7,392 | $0.00 | $0 | 0 | 8/29/2023 Filed: 8/30/2023 | Filing → |
REPLIGEN CORP RGEN | Sale | 850 | $171.38 | $146K | 83,741 | 8/29/2023 Filed: 8/30/2023 | Filing → |
REPLIGEN CORP RGEN | Exercise | 7,392 | $18.12 | $134K | 84,591 | 8/29/2023 Filed: 8/30/2023 | Filing → |
REPLIGEN CORP RGEN | Award | 1,730 | $0.00 | $0 | 1,730 | 5/18/2023 Filed: 5/22/2023 | Filing → |
REPLIGEN CORP RGEN | Award | 798 | $0.00 | $0 | 77,199 | 5/18/2023 Filed: 5/22/2023 | Filing → |
Vaccitech plc VACC | Award | 19,197 | $0.00 | $0 | 19,197 | 5/11/2023 Filed: 5/12/2023 | Filing → |
REPLIGEN CORP RGEN | Sale | 775 | $227.17 | $176K | 76,401 | 9/9/2022 Filed: 9/9/2022 | Filing → |
REPLIGEN CORP RGEN | Award | 1,565 | $0.00 | $0 | 1,565 | 5/26/2022 Filed: 5/31/2022 | Filing → |
REPLIGEN CORP
RGEN
Type
Sale
Shares
275
Price
$161.00
Value
$44K
Type
Award
Shares
20,174
Price
-
Value
-
REPLIGEN CORP
RGEN
Type
Award
Shares
1,800
Price
-
Value
-
REPLIGEN CORP
RGEN
Type
Award
Shares
973
Price
-
Value
-
REPLIGEN CORP
RGEN
Type
Exercise
Shares
2,953
Price
-
Value
-
REPLIGEN CORP
RGEN
Type
Exercise
Shares
2,953
Price
$67.71
Value
$200K
REPLIGEN CORP
RGEN
Type
Award
Shares
1,576
Price
-
Value
-
REPLIGEN CORP
RGEN
Type
Award
Shares
803
Price
-
Value
-
Type
Award
Shares
19,516
Price
-
Value
-
REPLIGEN CORP
RGEN
Type
Exercise
Shares
4,626
Price
-
Value
-
REPLIGEN CORP
RGEN
Type
Sale
Shares
1,000
Price
$193.35
Value
$193K
REPLIGEN CORP
RGEN
Type
Exercise
Shares
4,626
Price
$42.07
Value
$195K
REPLIGEN CORP
RGEN
Type
Exercise
Shares
7,392
Price
$0.00
Value
$0
REPLIGEN CORP
RGEN
Type
Sale
Shares
850
Price
$171.38
Value
$146K
REPLIGEN CORP
RGEN
Type
Exercise
Shares
7,392
Price
$18.12
Value
$134K
REPLIGEN CORP
RGEN
Type
Award
Shares
1,730
Price
$0.00
Value
$0
REPLIGEN CORP
RGEN
Type
Award
Shares
798
Price
$0.00
Value
$0
Vaccitech plc
VACC
Type
Award
Shares
19,197
Price
$0.00
Value
$0
REPLIGEN CORP
RGEN
Type
Sale
Shares
775
Price
$227.17
Value
$176K
REPLIGEN CORP
RGEN
Type
Award
Shares
1,565
Price
$0.00
Value
$0
AI Agent
Try asking...